Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, April 10, 2019
[ Wed, Apr 10th 2019
] - WOPRAI
[ Wed, Apr 10th 2019
] - WOPRAI
[ Wed, Apr 10th 2019
] - WOPRAI
[ Wed, Apr 10th 2019
] - WOPRAI
[ Wed, Apr 10th 2019
] - WOPRAI
[ Wed, Apr 10th 2019
] - WOPRAI
[ Wed, Apr 10th 2019
] - WOPRAI
[ Wed, Apr 10th 2019
] - WOPRAI
[ Wed, Apr 10th 2019
] - WOPRAI
[ Wed, Apr 10th 2019
] - WOPRAI
[ Wed, Apr 10th 2019
] - WOPRAI
Tue, April 9, 2019
[ Tue, Apr 09th 2019
] - WOPRAI
[ Tue, Apr 09th 2019
] - WOPRAI
[ Tue, Apr 09th 2019
] - WOPRAI
[ Tue, Apr 09th 2019
] - WOPRAI
[ Tue, Apr 09th 2019
] - WOPRAI
[ Tue, Apr 09th 2019
] - WOPRAI
[ Tue, Apr 09th 2019
] - WOPRAI
[ Tue, Apr 09th 2019
] - WOPRAI
[ Tue, Apr 09th 2019
] - WOPRAI
[ Tue, Apr 09th 2019
] - WOPRAI
[ Tue, Apr 09th 2019
] - WOPRAI
[ Tue, Apr 09th 2019
] - WOPRAI
[ Tue, Apr 09th 2019
] - WOPRAI
[ Tue, Apr 09th 2019
] - WOPRAI
[ Tue, Apr 09th 2019
] - WOPRAI
Do Kim Maintained (ALNY) at Buy with Increased Target to $119 on, Apr 9th, 2019
Do Kim of BMO Capital, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Buy with Increased Target from $106 to $119 on, Apr 9th, 2019.
Do has made no other calls on ALNY in the last 4 months.
There are 2 other peers that have a rating on ALNY. Out of the 2 peers that are also analyzing ALNY, 1 agrees with Do's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Esther Rajavelu of "UBS" Initiated at Hold on, Wednesday, January 23rd, 2019
This is the rating of the analyst that currently disagrees with Do
- David Lebovitz of "Morgan Stanley" Upgraded from Hold to Buy on, Tuesday, March 5th, 2019
